AI Science Tracker

Bayesian optimization identifies a methane-combustion catalyst formula

Beihang University · 12 Oct 2023 · materials

Discovery

Bayesian optimization identifies a methane-combustion catalyst formula

Bayesian optimization guided the experimental search over Pt/Pd and Ce/Zr ratios in PtPd@CeZrOx core–shell nanospheres. The authors report that two optimization rounds comprising 18 experiments found a formula with methane-conversion T50 approaching 330 °C, lower than prior reports cited by the study. The full assay conditions and comparison basis were not reviewed here; this is a bounded laboratory result, not a claim of general superiority, durability, or deployment.

Technology: Bayesian optimization for experimental catalyst-formula selection

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The publisher abstract reports that BO guided two experimental optimization rounds (18 experiments total) and that the selected PtPd@CeZrOx formula reached a methane-conversion T50 approaching 330 °C.
  • Still unknown: Full test conditions, exact comparator basis, replicate variability and durability were not assessed in this abstract-limited review. The reported T50 does not establish field emissions performance or general superiority.
  • AI role: Bayesian optimization selected multi-component Pt/Pd and Ce/Zr catalyst-formula ratios across iterative experiments; the reported T50 is the measured outcome associated with the selected formula.

Evidence sources: https://onlinelibrary.wiley.com/doi/10.1002/anie.202313068 · https://pubmed.ncbi.nlm.nih.gov/37823845/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Primary Wiley publisher abstract/indexed article text and PubMed primary metadata/abstract read. Full article Methods/Results and supporting information were not accessible..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.